These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33378607)

  • 1. A New Vaccine to Battle Covid-19.
    Haynes BF
    N Engl J Med; 2021 Feb; 384(5):470-471. PubMed ID: 33378607
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
    Swift MD; Breeher LE; Tande AJ; Tommaso CP; Hainy CM; Chu H; Murad MH; Berbari EF; Virk A
    Clin Infect Dis; 2021 Sep; 73(6):e1376-e1379. PubMed ID: 33900384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.
    Hajissa K; Mussa A
    Hum Vaccin Immunother; 2021 Aug; 17(8):2445-2447. PubMed ID: 33830862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
    Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
    Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Plotkin SA; Halsey N
    Clin Infect Dis; 2021 Oct; 73(7):1320-1321. PubMed ID: 33502467
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
    Canaday DH; Carias L; Oyebanji OA; Keresztesy D; Wilk D; Payne M; Aung H; St Denis K; Lam EC; Rowley CF; Berry SD; Cameron CM; Cameron MJ; Wilson B; Balazs AB; Gravenstein S; King CL
    Clin Infect Dis; 2021 Dec; 73(11):2112-2115. PubMed ID: 33993265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How important is the second dose of the COVID-19 mRNA vaccine?
    Liu AY
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2537. PubMed ID: 34112480
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.
    Rodríguez C; Pérez-Nieva A; Máiz L; Meijón MDM; Llamas P; Monreal M; Bikdeli B; Jiménez D
    Thromb Res; 2021 Dec; 208():1-3. PubMed ID: 34649161
    [No Abstract]   [Full Text] [Related]  

  • 10. Three doses of mRNA COVID-19 vaccine protects from SARS-CoV-2 infections in Japan.
    Hotta K; Suzuki E; Ichihara E; Kiura K
    J Intern Med; 2022 Oct; 292(4):687-689. PubMed ID: 35612543
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US authorization of first COVID vaccine marks new phase in safety monitoring.
    Ledford H
    Nature; 2020 Dec; 588(7838):377-378. PubMed ID: 33311629
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty
    Ando M; Satonaga Y; Takaki R; Yabe M; Kan T; Omote E; Yamasaki T; Komiya K; Hiramatsu K
    Int J Infect Dis; 2022 Nov; 124():187-189. PubMed ID: 36122668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Maeda H; Saito N; Igarashi A; Ishida M; Suami K; Yagiuchi A; Kimura Y; Komino M; Arai H; Morikawa T; Motohashi I; Miyazawa R; Moriyama T; Kamura H; Terada M; Kuwamitsu O; Hayakawa T; Sando E; Ohara Y; Teshigahara O; Suzuki M; Morimoto K
    Clin Infect Dis; 2022 Nov; 75(11):1971-1979. PubMed ID: 35438137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG skin testing for COVID-19 vaccine allergy.
    Stone BD
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765. PubMed ID: 33838847
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19.
    Vollmann D; Eiffert H; Schuster A
    Dtsch Arztebl Int; 2021 Aug; 118(31-32):546. PubMed ID: 34515024
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine.
    Salvagno GL; Henry BM; Lippi G
    J Occup Environ Med; 2021 Nov; 63(11):e829. PubMed ID: 34412098
    [No Abstract]   [Full Text] [Related]  

  • 19. [Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].
    Nieto Colino S; Cid Abasolo FJ; Martínez Hernández J
    Rev Esp Geriatr Gerontol; 2021; 56(5):312-313. PubMed ID: 34172313
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    Blumenthal KG; Phadke NA; Bates DW
    JAMA; 2021 Oct; 326(14):1375-1377. PubMed ID: 34477809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.